MitoxantroneVeinsSaphenous VeinPortal VeinVaricose VeinsFemoral VeinPulmonary VeinsJugular VeinsAnthraquinonesCytarabineAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsMesenteric VeinsRenal VeinsATP-Binding Cassette TransportersUmbilical VeinsIliac VeinHepatic VeinsDrug Resistance, MultiplePopliteal VeinDrug Resistance, NeoplasmPrednisoneVidarabineDoxorubicinEtoposideDaunorubicinSubclavian VeinSplenic VeinIdarubicinP-GlycoproteinNeoplasm ProteinsCerebral VeinsAmsacrineRazoxaneRemission InductionTopoisomerase InhibitorsTreatment OutcomeIntercalating AgentsTaxoidsRetinal VeinEstramustineTopotecanAzygos VeinBrachiocephalic VeinsCardiotoxinsDrug EvaluationCyclophosphamideLeukemia, MyeloidAxillary VeinProstatic NeoplasmsRetinal Vein OcclusionDrug Administration ScheduleDNA Topoisomerases, Type IILeukemia, Myeloid, Acute